COMMUNIQUÉS West-GlobeNewswire

NeurAxis to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
18/09/2025
CARMEL, Ind., Sept. 18, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and [...]
Lipella Pharmaceuticals Announces Positive Final Results from Phase 2a Study of LP-10 in Oral Lichen Planus
18/09/2025
All 27 patients completed treatment with no serious adverse events, underscoring a favorable safety profile Statistically significant improvements achieved across all efficacy endpoints at the 4-week timepoint Preparing [...]
MindRank Presented Clinical Update on Oral GLP-1RA MDR-001 at LSX World Congress, Highlighting AI-Powered Innovation
18/09/2025
HANGZHOU, China and LONDON, Sept. 18, 2025 (GLOBE NEWSWIRE) -- MindRank, a clinical-stage artificial intelligence (AI)-empowered drug discovery company, was invited to present at the 2025 LSX World Congress in Boston. [...]
Curonix Expands the Freedom® PNS System Patient Treatment Options with the Launch of its Innovative Wearable Solution for Chronic Pain of the Head, Neck, Shoulder, and Torso
18/09/2025
POMPANO BEACH, Fla., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Curonix LLC, a leading medical technology company specializing in opioid-free chronic pain relief, today announced the launch of its next-generation wearable [...]
LifeMD Expands Pharmacy Services with Non-Sterile Compounding to Deliver Personalized, Cost-Efficient Therapies at Scale
18/09/2025
Enhanced Affiliated Pharmacy Capabilities Support Specialized Therapies, Seamless Patient Experience, and Margin Expansion NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of [...]
Commure Named to the 2025 Fortune Future 50 List
18/09/2025
Commure is redefining how America’s largest industry can run smarter, faster, and more human with AI MOUNTAIN VIEW, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Commure , a leading healthcare technology company, today [...]
Elicio Therapeutics Reports Inducement Grants
18/09/2025
BOSTON, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of [...]
Tonix Pharmaceuticals Announces Positive Pre-IND Meeting with FDA for TNX-102 SL for the Treatment of Major Depressive Disorder
18/09/2025
Tonix anticipates filing the IND application in the fourth quarter of 2025 TNX-102 SL is a potential first-in-class treatment for targeting the disturbed sleep associated with depression TNX-102 SL is FDA-approved for [...]
atai Life Sciences Awarded Grant from the National Institutes of Health
18/09/2025
5-year UG3/UH3 grant will fund the optimization and early-stage development of atai’s novel 5-HT2A/2C receptor agonists with non-hallucinogenic potential for opioid use disorder NEW YORK and AMSTERDAM, Sept. 18, 2025 ( [...]
Nanox Announces Multi-Segment Healthcare Collaboration with Monarch Medical Management to Expand Access to Advanced Medical Imaging
18/09/2025
Collaboration spans workers' compensation, nursing homes, and outpatient clinics PETACH TIKVA, Israel, Sept. 18, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative [...]
NKGen Biotech to Present on the Use of Troculeucel for Neurodegenerative Diseases at the 3rd China Great Bay Cell and Gene Therapy Forum
18/09/2025
SANTA ANA, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative [...]
La 37e édition du Shrine Bowl Canada : une tradition de soutien aux patients de l’Hôpital Shriners pour enfants Canada
18/09/2025
MONTRÉAL, 18 sept. 2025 (GLOBE NEWSWIRE) -- La 37e édition du Shrine Bowl du Canada se tiendra le samedi 20 septembre à 13 h au Stade Concordia, 7200 rue Sherbrooke Ouest à Montréal . Chaque année, ce match sensibilise [...]
37th Edition of Shrine Bowl Canada: A Tradition of Support for Patients at Shriners Hospitals for Children Canada
18/09/2025
MONTREAL, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The 37th edition of Canada’s Shrine Bowl will take place on Saturday, September 20 at 1:00 p.m. at Concordia Stadium, 7200 Sherbrooke Street West in Montreal. Each year, this [...]
Grace Therapeutics Granted Sixth U.S. Patent Covering I.V. Dosing Regimen for GTx-104
18/09/2025
Grant of First Method of Use Patent Adds New Pillar to Grace’s Multi-layered Intellectual Property and Potential Market Exclusivity Protection Patent Coverage Extended to 2043 PRINCETON, N.J., Sept. 18, 2025 (GLOBE [...]
Wave Life Sciences Announces Virtual Research Day on October 29th and Participation at Upcoming Investor Conferences
18/09/2025
CAMBRIDGE, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, [...]
Cannabix Technologies to Participate at U.S. National Institute of Standards and Technology (NIST) Cannabis Breathalyzer Workshop
18/09/2025
VANCOUVER, British Columbia, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing [...]
Achieve Life Sciences Promotes Craig Donnelly to Chief Operations Officer
18/09/2025
Donnelly brings more than 25 years of biopharmaceutical expertise in CMC and regulatory operations SEATTLE and VANCOUVER, British Columbia, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), [...]
Clover Health Celebrates the Election of Dr. Ian Duncan, Clover MA Board Member, as the 2025-2026 President-Elect and Vice-Chair of the Society of Actuaries
18/09/2025
Dr. Duncan's appointment to this prestigious role recognizes his extraordinary contributions to the actuarial profession and healthcare innovation over three decades WILMINGTON, Del., Sept. 18, 2025 (GLOBE NEWSWIRE) -- [...]
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Creating Pioneering Pipeline Designed to Transform Cancer, Rare Diseases Treatments
18/09/2025
NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the [...]

Pages